Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

314 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Drug-Induced Fatty Liver Disease (DIFLD): A Comprehensive Analysis of Clinical, Biochemical, and Histopathological Data for Mechanisms Identification and Consistency with Current Adverse Outcome Pathways.
López-Pascual E, Rienda I, Perez-Rojas J, Rapisarda A, Garcia-Llorens G, Jover R, Castell JV. López-Pascual E, et al. Among authors: rapisarda a. Int J Mol Sci. 2024 May 10;25(10):5203. doi: 10.3390/ijms25105203. Int J Mol Sci. 2024. PMID: 38791241 Free PMC article. Review.
Corrigendum to "Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support" [Biomed. Pharmacother. 174 (2024) 116530].
Moreno-Torres M, López-Pascual E, Rapisarda A, Quintás G, Drees A, Steffensen IL, Luechtefeld T, Serrano-Candelas E, de Lomana MG, Gadaleta D, Dirven H, Vinken M, Jover R. Moreno-Torres M, et al. Among authors: rapisarda a. Biomed Pharmacother. 2024 May 23:116813. doi: 10.1016/j.biopha.2024.116813. Online ahead of print. Biomed Pharmacother. 2024. PMID: 38789350 Free article. No abstract available.
Stereoscopic Monitoring technique for motor area tumors.
Della Pepa GM, Di Domenico M, Ceccarelli GM, Burattini B, Menna G, Rapisarda A, Viola D, Marino S, Mattogno PP, Olivi A, Doglietto F. Della Pepa GM, et al. Among authors: rapisarda a. World Neurosurg. 2024 May 16:S1878-8750(24)00818-0. doi: 10.1016/j.wneu.2024.05.056. Online ahead of print. World Neurosurg. 2024. PMID: 38759785
A quantitative weight-of-evidence method for confidence assessment of adverse outcome pathway networks: A case study on chemical-induced liver steatosis.
Verhoeven A, van Ertvelde J, Boeckmans J, Gatzios A, Jover R, Lindeman B, Lopez-Soop G, Rodrigues RM, Rapisarda A, Sanz-Serrano J, Stinckens M, Sepehri S, Teunis M, Vinken M, Jiang J, Vanhaecke T. Verhoeven A, et al. Among authors: rapisarda a. Toxicology. 2024 Apr 25;505:153814. doi: 10.1016/j.tox.2024.153814. Online ahead of print. Toxicology. 2024. PMID: 38677583
Novel clinical phenotypes, drug categorization, and outcome prediction in drug-induced cholestasis: Analysis of a database of 432 patients developed by literature review and machine learning support.
Moreno-Torres M, López-Pascual E, Rapisarda A, Quintás G, Drees A, Steffensen IL, Luechtefeld T, Serrano-Candelas E, de Lomana MG, Gadaleta D, Dirven H, Vinken M, Jover R. Moreno-Torres M, et al. Among authors: rapisarda a. Biomed Pharmacother. 2024 May;174:116530. doi: 10.1016/j.biopha.2024.116530. Epub 2024 Apr 3. Biomed Pharmacother. 2024. PMID: 38574623 Free article. Review.
314 results